Literature DB >> 10432522

The effect of cigarette smoke constituents on the expression of HLA-DR in orbital fibroblasts derived from patients with Graves ophthalmopathy.

W P Mack1, G O Stasior, H J Cao, O G Stasior, T J Smith.   

Abstract

PURPOSE: Numerous studies have established a strong association between smoking and Graves disease, but the underlying mechanism of Graves ophthalmopathy has not been elucidated. Recent studies of Graves ophthalmopathy have focused on the orbital fibroblast as an integral component in the pathogenesis of this disorder. This investigation focuses on the effect of cigarette smoke constituents, nicotine and tar, to alter the expression of human leukocyte antigen (HLA-DR) in cultured orbital fibroblasts from patients with Graves disease.
METHODS: HLA-DR expression was quantified by scanning densitometry of whole cell lysates subjected to sodium dodecyl sulfate--polyacrylamide gel electrophoresis with immunoblotting and also by direct immunofluorescence.
RESULTS: Cultured orbital fibroblasts, obtained from patients undergoing orbital decompression for severe Graves ophthalmopathy, failed to express HLA-DR as analyzed by both immunoblotting and direct immunofluorescence when treated with nicotine alone (25-300 ng/ml). The expression of HLA-DR increased three-fold when nicotine (25 ng/ml) in combination with interferon-gamma (500 U/ml) was added to the cultured orbital fibroblasts (p < 0.0001). Cultured orbital fibroblasts treated with tar alone (60-600 ng/ml) failed to exhibit HLA-DR expression as assessed by direct immunofluorescence and immunoblotting. A greater than two-fold increase in HLA-DR expression occurred when tar (600 ng/ml) combined with interferon-gamma (500 U/ml) was added to the cultured orbital fibroblasts (p < 0.0001).
CONCLUSION: The results suggest a possible molecular mechanism for the more severe ophthalmopathy observed in Graves patients who smoke cigarettes. These findings could prove useful for possible medical interventions to decrease or even inhibit the interaction between cigarette constituents, cytokines, and orbital fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10432522     DOI: 10.1097/00002341-199907000-00007

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  6 in total

Review 1.  Unlocking the immunological mechanisms of orbital inflammation in thyroid eye disease.

Authors:  M Ludgate; G Baker
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

2.  Smoking and disease severity are independent determinants of serum adhesion molecule levels in Graves' ophthalmopathy.

Authors:  I M M J Wakelkamp; M N Gerding; J W C van der Meer; M F Prummel; W M Wiersinga
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

3.  Different Effects of Cigarette Smoke, Heated Tobacco Product and E-Cigarette Vapour on Orbital Fibroblasts in Graves' Orbitopathy; a Study by Real Time Cell Electronic Sensing.

Authors:  Janos K Aranyosi; Erika Galgoczi; Annamaria Erdei; Monika Katko; Mariann Fodor; Zoltan Ujhelyi; Ildiko Bacskay; Endre V Nagy; Bernadett Ujhelyi
Journal:  Molecules       Date:  2022-05-07       Impact factor: 4.927

4.  Smoking and multiple sclerosis: an updated meta-analysis.

Authors:  Adam E Handel; Alexander J Williamson; Giulio Disanto; Ruth Dobson; Gavin Giovannoni; Sreeram V Ramagopalan
Journal:  PLoS One       Date:  2011-01-13       Impact factor: 3.240

5.  It takes two to Tango: IGF-I and TSH Receptors in Thyroid Eye Disease.

Authors:  Leonard Girnita; Terry J Smith; Joseph A M J L Janssen
Journal:  J Clin Endocrinol Metab       Date:  2022-02-15       Impact factor: 6.134

6.  HLA Class I Upregulation and Antiviral Immune Responses in Graves Disease.

Authors:  Therese Weider; Sarah J Richardson; Noel G Morgan; Trond H Paulsen; Knut Dahl-Jørgensen; Sara Salehi Hammerstad
Journal:  J Clin Endocrinol Metab       Date:  2021-03-25       Impact factor: 5.958

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.